North America ECMO Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America ECMO Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America ECMO Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America ECMO Market Regional Analysis

6.2 North America ECMO Market Revenue 2020-2028 (US$ Million)

6.3 North America ECMO Market Forecast Analysis

7. North America ECMO Market Analysis – by Modality

7.1 Venoarterial ECMO

7.1.1 Overview
7.1.2 Venoarterial ECMO: North America ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Venovenous ECMO

7.2.1 Overview
7.2.2 Venovenous ECMO: North America ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Arteriovenous ECMO

7.3.1 Overview
7.3.2 Arteriovenous ECMO: North America ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America ECMO Market Analysis – by Application

8.1 Respiratory

8.1.1 Overview
8.1.2 Respiratory: North America ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Cardiology

8.2.1 Overview
8.2.2 Cardiology: North America ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. North America ECMO Market Analysis – by Age Group

9.1 Adults

9.1.1 Overview
9.1.2 Adults: North America ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Pediatrics

9.2.1 Overview
9.2.2 Pediatrics: North America ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Neonates

9.3.1 Overview
9.3.2 Neonates : North America ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. North America ECMO Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America ECMO Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 North America ECMO Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America ECMO Market Breakdown, by Modality
10.2.1.1.2 US: North America ECMO Market Breakdown, by Application
10.2.1.1.3 US: North America ECMO Market Breakdown, by Age Group

10.2.1.2 Canada: North America ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America ECMO Market Breakdown, by Modality
10.2.1.2.2 Canada: North America ECMO Market Breakdown, by Application
10.2.1.2.3 Canada: North America ECMO Market Breakdown, by Age Group

10.2.1.3 Mexico : North America ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America ECMO Market Breakdown, by Modality
10.2.1.3.2 Mexico : North America ECMO Market Breakdown, by Application
10.2.1.3.3 Mexico : North America ECMO Market Breakdown, by Age Group

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 ABIOMED Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Braile Biomedica

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Eurosets S.R.L.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Fresenius Medical Care AG & Co KGaA

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Getinge AB

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 LivaNova Plc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Medtronic Plc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 MicroPort Scientific Corporation

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Nipro Medical Corporation

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Terumo Group

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America ECMO Market

Analysis – by Modality (Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO), Application (Respiratory and Cardiology), and Age Group (Adults, Pediatrics, and Neonates)